Loading institutional data...
Loading institutional data...
Held by 173 of 5,944 reporting institutions (90th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$47M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 5 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -78%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 5 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $280M covers all $14M of scheduled principal — no refinancing pressure. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~28.0% on $2M of debt.
Cash of $280M fully covers short-term debt of $584000.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $23.8M 100.0% | $4.1M 100.0% | $433K 100.0% | $0 | — |
| Cost of Revenue | $20.4M 85.7% | $2.5M 61.4% | $294K 67.9% | $0 | — |
| Gross Profit | $3.4M 14.3% | $1.6M 38.6% | $139K 32.1% | $0 | — |
| Research & Development | $12.4M 51.8% | $3.1M 75.7% | $765K 176.6% | $1.3M | — |
| Selling, General & Admin | $48.2M 202.3% | $24.8M 598.8% | $15.4M 3560.2% | $3.8M | — |
| Total Operating Expenses | $63.3M 265.5% | $28.0M 674.5% | $16.2M 3736.7% | $5.1M | — |
| Operating Income | -$59.9M -251.2% | -$26.4M -636.0% | -$16.0M -3704.6% | -$5.1M | — |
| Interest Expense | $575K 2.4% | $259K 6.3% | $119K 27.4% | $0 | — |
| Interest & Investment Income | $6.8M 28.5% | $1.2M 29.9% | $9K 2.1% | $3K | — |
| Other Income (Expense), net | -$99.7M -417.8% | -$6.0M -143.8% | -$258K -59.6% | $154K | — |
| Pretax Income | -$159.6M -669.0% | -$32.3M -779.7% | -$16.3M -3764.3% | -$4.9M | — |
| Income Tax Expense | $282K 1.2% | $111K 2.7% | -$6K -1.4% | $0 | — |
| Net Income | -$159.8M -670.2% | -$32.4M -782.4% | -$16.3M -3762.9% | -$4.9M | — |
| Per Share | |||||
| EPS (Basic) | $-2.11 | $-0.63 | $-0.49 | $-0.18 | $-0.18 |
| EPS (Diluted) | $-2.11 | $-0.63 | $-0.49 | — | — |
| Weighted Avg Shares (Basic) | 83.0M | 55.7M | 33.1M | 26.8M | — |
| Weighted Avg Shares (Diluted) | 83.0M | 55.7M | 33.1M | — | — |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
EOD close · as of 2026-09-17
Where each multiple sits in its own 4-yr range · 0th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 4-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Low operating leverage — profit tracks sales closely (stable, less cyclical).
Each line as % of revenue — the trend in color
| % of revenue | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cost of Revenue | — | — | 67.9 | 61.4 | 85.7 |
| Gross Profit | — | — | 32.1 | 38.6 | 14.3 |
| R&D | — | — | 176.6 | 75.7 | 51.8 |
| SG&A | — | — | 3560.2 | 598.8 | 202.3 |
| Operating Income | — | — | -3704.6 | -636.0 | -251.2 |
| Income Tax | — | — | -1.4 | 2.7 | 1.2 |
| Net Income | — | — | -3762.9 | -782.4 | -670.2 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on ASPI: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Ranked against 238 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BHP | $427.1B | — | — | — | — | — | — | — | — | — | 713 |
| LIN | $216.9B | 31.6× | 19.5× | 6.4× | 3.0% | — | 20.3% | 18.0% | 10.9% | 2.1× | 2,148 |
| SCCO | $157.0B | 36.2× | 20.3× | 11.7× | 17.4% | 60.1% | 32.4% | 39.4% | 24.4% | 0.9× | 791 |
| CX | $147.4B | — | — | — | — | — | — | — | — | — | 297 |
| TX | $114.2B | — | — | — | — | — | — | — | — | — | 139 |
| FCX | $99.5B | — | 12.0× | 3.8× | 1.8% | 28.2% | 16.0% | 22.0% | 14.7% | 1.1× | 1,775 |
| AEM | $97.8B | — | — | — | — | — | — | — | — | — | 1,066 |
| SHW | $79.6B | 31.3× | — | 3.4× | 2.1% | 48.8% | 10.9% | 55.9% | 17.0% | — | 1,610 |
| ECL | $77.3B | 37.6× | 22.7× | 4.8× | 2.2% | 44.5% | 12.9% | 21.2% | 19.5% | 0.3× | 1,619 |
| B | $71.3B | — | — | — | — | — | — | — | — | — | 979 |
| WPM | $66.6B | — | — | — | — | — | — | — | — | — | 809 |
| APD | $63.9B | — | 90.3× | 5.3× | -0.5% | 31.4% | -3.3% | -2.6% | -2.6% | 0.1× | 1,702 |
| NUE | $60.1B | 34.7× | — | 1.9× | 5.7% | 11.9% | 5.4% | 8.3% | 8.3% | — | 1,325 |
| VALE | $60.1B | — | — | — | — | — | — | — | — | — | 537 |
| CRH | $58.0B | 15.7× | 9.3× | 1.6× | 5.3% | 36.1% | 10.0% | 15.6% | 9.2% | 2.2× | 9 |
| MT | $55.7B | — | — | — | — | — | — | — | — | — | 286 |
| DD | $53.3B | — | — | 7.8× | 1.9% | 34.5% | -11.4% | -5.6% | -5.6% | — | 1,172 |
| AU | $50.4B | — | — | — | — | — | — | — | — | — | 537 |
| FNV | $50.0B | — | — | — | — | — | — | — | — | — | 614 |
| NTR | $37.1B | — | — | — | — | — | — | — | — | — | 718 |
| STLD | $34.5B | 29.8× | 18.7× | 1.9× | 3.6% | 13.2% | 6.5% | 13.2% | 9.0% | 2.1× | 893 |
| KGC | $33.4B | — | — | — | — | — | — | — | — | — | 630 |
| VMC | $31.9B | 30.1× | 15.2× | 4.0× | 7.1% | 27.4% | 13.6% | 12.6% | 8.4% | 1.8× | 981 |
| MLM | $30.0B | 26.5× | 17.0× | 4.9× | 8.6% | 30.7% | 18.5% | 11.3% | 7.4% | 2.6× | 1,022 |
| PPG | $23.5B | 15.1× | — | 1.5× | 0.2% | 41.3% | 9.9% | 19.8% | 10.3% | — | 1,003 |
| ASPI | $352M | — | — | 14.8× | 476% | 14.3% | -670% | -78.3% | -77.5% | -0.0× | 173 |
Peers = companies sharing ASPI's sector (Basic Materials) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.